Technetium Succimer

Technetium succimer (99mTc-DMSA, dimercaptosuccinic acid) is a renal cortical imaging agent that binds to proximal renal tubular cells, providing high-resolution static scintigraphic images of the renal cortex to assess renal parenchymal integrity and scarring. It is considered the gold standard for detecting renal cortical scarring from pyelonephritis, particularly in children, and for measuring differential renal function. Its high cortical uptake and retention make it ideal for anatomical rather than functional renal assessment.

Yes, Technetium Succimer is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.